Yinghua Lv
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 01, 2024
A nanoplatform based on allylthiopurine bio-MOF and glycosylated AIE PARP inhibitor for cancer synthetic lethal therapy.Bingling Gao, Ke Yang, Manman Yang
|Jan 05, 2024
Mn(iii)-mediated carbon-centered radicals generate an enhanced immunotherapeutic effect.Jiaxuan Li, Baifei Hu, Zelong Chen
|Mar 13, 2023
Supramolecular nanoprodrug based on a chloride channel blocker and glycosylated pillar[5]arenes for targeted chemoresistance cancer therapy.Ke Yang, Ke Ma, Manman Yang
|Sep 15, 2022
A supramolecular nano-delivery system based on AIE PARP inhibitor prodrug and glycosylated pillar[5]arene for drug-resistance therapy.Manman Yang, Ke Yang, Bingling Gao
Pageof 1
